Rewriting Life Big Pharma Doubles Down on CRISPR for New Drugs A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body. by Mike Orcutt 2016-01-13T00:00:00-05:00
Rewriting Life CRISPR Gene Editing to Be Tested on People by 2017, Says Editas A biotechnology company says it will test advanced gene-engineering methods to treat blindness. by Antonio Regalado 2015-11-05T00:00:00-05:00
Rewriting Life Gene-Editing Startup Raises $120 Million to Apply CRISPR to Medicine A company started by several gene-editing pioneers gets new funding to develop treatments for blood cancers, eye diseases, and sickle-cell anemia. by Anna Nowogrodzki 2015-08-10T07:30:00-04:00
